LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 56.24 | 17.25 | 6 | 4929 | 0.0012 | -0.1214 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 56.24 | 17.25 | 4624 | 4929 | 0.9381 | 0.9844 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 58.21 | 17.25 | 10 | 4942 | 0.0020 | -0.0646 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 58.21 | 17.25 | 4310 | 4942 | 0.8720 | 0.9667 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 58.21 | 17.25 | 3836 | 4942 | 0.7761 | 0.9389 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 58.21 | 17.25 | 4294 | 4942 | 0.8688 | 0.9658 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 58.21 | 17.25 | 9 | 4942 | 0.0018 | -0.0766 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 58.21 | 17.25 | 4879 | 4942 | 0.9872 | 0.9968 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 60.18 | 17.25 | 14 | 5031 | 0.0028 | -0.0252 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 60.18 | 17.25 | 4620 | 5031 | 0.9182 | 0.9793 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 60.18 | 17.25 | 3991 | 5031 | 0.7932 | 0.9442 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 60.18 | 17.25 | 4499 | 5031 | 0.8942 | 0.9729 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 60.18 | 17.25 | 9 | 5031 | 0.0018 | -0.0764 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 60.18 | 17.25 | 5110 | 5031 | 1.0156 | 1.0038 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 63.15 | 17.25 | 13 | 5061 | 0.0026 | -0.0339 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 63.15 | 17.25 | 4808 | 5061 | 0.9500 | 0.9875 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 63.15 | 17.25 | 4466 | 5061 | 0.8824 | 0.9697 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 63.15 | 17.25 | 4759 | 5061 | 0.9403 | 0.9850 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 63.15 | 17.25 | 11 | 5061 | 0.0022 | -0.0534 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 63.15 | 17.25 | 5272 | 5061 | 1.0417 | 1.0100 | MN20160310_N02 | N12 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 65.12 | 17.25 | 18 | 5095 | 0.0035 | 0.0052 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 65.12 | 17.25 | 5100 | 5095 | 1.0009 | 1.0002 | MN20160310_N02 | G13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 65.12 | 17.25 | 4380 | 5095 | 0.8596 | 0.9635 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 65.12 | 17.25 | 4924 | 5095 | 0.9664 | 0.9917 | MN20160310_N02 | K07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 65.12 | 17.25 | 11 | 5095 | 0.0022 | -0.0534 | MN20160310_N02 | N12 |